FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2048488110> ?p ?o ?g. }

• W2048488110 endingPage "456" @default.
• W2048488110 startingPage "441" @default.
• W2048488110 abstract "1. A new assay to quantify mRNA levels in small numbers of rat hepatocytes has been developed for cytochrome P450 (CYP) isoforms 1A1, 1A2, 3A and 4A1. The assay uses sets of oligonucleotide probes end-labelled with [35S]-dATP to hybridize to mRNA in control- or drug-treated rat hepatocytes cultured on Cytostar-T 96-well scintillating microplates. 2. The rat hepatocyte induction potential (RHIP) assays for CYP3A, 1A1, 1A2 and 4A1 are sensitive and selective and have an excellent qualitative relationship with CYP induction data ex vivo. The robustness of the CYP3A assay was determined following a run of > 40 plates. The variation of the dexamethasone (DEX) response on each plate, calculated as %coefficient of variation, showed that there was no significant difference between the variability of the response to DEX. 3. Assay specificity for each CYP isoform was achieved by designing probes (four per isoform) antisense to coding regions of each CYP gene sequence. In the CYP3A RHIP assay, pregnenalone 16alpha-carbonitrile (PCN), DEX, clotrimazole (CLOT) and miconazole (MIC) were all good inducers of CYP3A mRNA; beta-napthoflavone (BNF) and methylclofenapate (MCP), however, did not induce CYP3A mRNA, further defining the specificity of this methodology. Specificity was similarly confirmed for the other CYP isoforms. 4. Ind50, the concentration of inducer required to elicit a 50% induction of CYP-specific mRNA, was derived for prototypical CYP inducers: BNF 0.54 and 0.17 microM (CYP1A1 and 1A2 respectively), 3-methylcholanthrene (3MC) 0.11 and 0.04 microM (CYP1A1 and 1A2 respectively), PCN 0.03 microM, DEX 0.17 microM, CLOT 0.48 microM, MIC 3 microM, TAO 3 microM (CYP3A), MCP 1.8 microM, clofibrate (CLOF) 65 microM and ciprofibrate (CIP) 1.9 microM (CYP4A1). Ind50 for BNF and 3MC at CYP1A2 was 3-fold lower than that at CYP1A1 indicating a subfamily difference in inducer potency. 5. Reducing the numbers of animals and the amount of compound required to study CYP induction is an important advantage of the RHIP assays over conventional evaluations in vivo. Typically four rats are dosed for 4 days using oral doses in the range 50-500 mg kg(-1) day(-1). In comparison, the amount of hepatocytes required to carry out all the studies reported herein may be obtained from a single animal (< 2 x 10(8) viable cells) and CYP induction investigated using microg rather than g quantities of drug substance. 6. With appropriately designed oligonucleotide probes, the RHIP technology can assess CYP induction in human hepatocytes, which together with preclinical data can contribute to improving the quality of compounds progressing into the expensive process of drug development." @default.
• W2048488110 created "2016-06-24" @default.
• W2048488110 creator A5000914912 @default.
• W2048488110 creator A5067159271 @default.
• W2048488110 creator A5067838760 @default.
• W2048488110 creator A5068059585 @default.
• W2048488110 creator A5082405249 @default.
• W2048488110 date "2000-01-01" @default.
• W2048488110 modified "2023-09-26" @default.
• W2048488110 title "Rapid determination of rat hepatocyte mRNA induction potential using oligonucleotide probes for CYP1A1, 1A2, 3A and 4A1" @default.
• W2048488110 cites W1550454984 @default.
• W2048488110 cites W1926862327 @default.
• W2048488110 cites W1969979837 @default.
• W2048488110 cites W1972985557 @default.
• W2048488110 cites W1973682542 @default.
• W2048488110 cites W1986000611 @default.
• W2048488110 cites W1991123381 @default.
• W2048488110 cites W1991822830 @default.
• W2048488110 cites W1995164189 @default.
• W2048488110 cites W1997722729 @default.
• W2048488110 cites W2011030044 @default.
• W2048488110 cites W2026746504 @default.
• W2048488110 cites W2031633834 @default.
• W2048488110 cites W2035000881 @default.
• W2048488110 cites W2044329308 @default.
• W2048488110 cites W2057661254 @default.
• W2048488110 cites W2059293500 @default.
• W2048488110 cites W2061542670 @default.
• W2048488110 cites W2080250010 @default.
• W2048488110 cites W2082524899 @default.
• W2048488110 cites W2084234371 @default.
• W2048488110 cites W2084462922 @default.
• W2048488110 cites W2106245429 @default.
• W2048488110 cites W2123998830 @default.
• W2048488110 cites W2129277308 @default.
• W2048488110 cites W2151724311 @default.
• W2048488110 cites W2165017352 @default.
• W2048488110 cites W2170214247 @default.
• W2048488110 cites W2271920375 @default.
• W2048488110 cites W2332605520 @default.
• W2048488110 cites W94341715 @default.
• W2048488110 doi "https://doi.org/10.1080/004982500237460" @default.
• W2048488110 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10875679" @default.
• W2048488110 hasPublicationYear "2000" @default.
• W2048488110 type Work @default.
• W2048488110 sameAs 2048488110 @default.
• W2048488110 citedByCount "7" @default.
• W2048488110 countsByYear W20484881102014 @default.
• W2048488110 crossrefType "journal-article" @default.
• W2048488110 hasAuthorship W2048488110A5000914912 @default.
• W2048488110 hasAuthorship W2048488110A5067159271 @default.
• W2048488110 hasAuthorship W2048488110A5067838760 @default.
• W2048488110 hasAuthorship W2048488110A5068059585 @default.
• W2048488110 hasAuthorship W2048488110A5082405249 @default.
• W2048488110 hasConcept C104317684 @default.
• W2048488110 hasConcept C105580179 @default.
• W2048488110 hasConcept C108190873 @default.
• W2048488110 hasConcept C11824378 @default.
• W2048488110 hasConcept C119795356 @default.
• W2048488110 hasConcept C132154277 @default.
• W2048488110 hasConcept C150194340 @default.
• W2048488110 hasConcept C153911025 @default.
• W2048488110 hasConcept C181199279 @default.
• W2048488110 hasConcept C194993378 @default.
• W2048488110 hasConcept C202751555 @default.
• W2048488110 hasConcept C2225953 @default.
• W2048488110 hasConcept C2776200302 @default.
• W2048488110 hasConcept C526171541 @default.
• W2048488110 hasConcept C53345823 @default.
• W2048488110 hasConcept C55493867 @default.
• W2048488110 hasConcept C86803240 @default.
• W2048488110 hasConceptScore W2048488110C104317684 @default.
• W2048488110 hasConceptScore W2048488110C105580179 @default.
• W2048488110 hasConceptScore W2048488110C108190873 @default.
• W2048488110 hasConceptScore W2048488110C11824378 @default.
• W2048488110 hasConceptScore W2048488110C119795356 @default.
• W2048488110 hasConceptScore W2048488110C132154277 @default.
• W2048488110 hasConceptScore W2048488110C150194340 @default.
• W2048488110 hasConceptScore W2048488110C153911025 @default.
• W2048488110 hasConceptScore W2048488110C181199279 @default.
• W2048488110 hasConceptScore W2048488110C194993378 @default.
• W2048488110 hasConceptScore W2048488110C202751555 @default.
• W2048488110 hasConceptScore W2048488110C2225953 @default.
• W2048488110 hasConceptScore W2048488110C2776200302 @default.
• W2048488110 hasConceptScore W2048488110C526171541 @default.
• W2048488110 hasConceptScore W2048488110C53345823 @default.
• W2048488110 hasConceptScore W2048488110C55493867 @default.
• W2048488110 hasConceptScore W2048488110C86803240 @default.
• W2048488110 hasIssue "5" @default.
• W2048488110 hasLocation W20484881101 @default.
• W2048488110 hasLocation W20484881102 @default.
• W2048488110 hasOpenAccess W2048488110 @default.
• W2048488110 hasPrimaryLocation W20484881101 @default.
• W2048488110 hasRelatedWork W1599426890 @default.
• W2048488110 hasRelatedWork W1994273373 @default.
• W2048488110 hasRelatedWork W2004920664 @default.
• W2048488110 hasRelatedWork W2035393916 @default.
• W2048488110 hasRelatedWork W2040546709 @default.

• next